• When PHG is symptomatic, corticosteroids are probably efficient to improve symptoms and nodule size 
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1.Introduction
Pulmonary hyalinizing granuloma (PHG) is a rare disease, which was first reported by 2 . This histologic pattern has also been described in isolated extra respiratory localizations 3 . PHG may be associated with mediastinal and retroperitoneal fibrosis, autoimmune, hematologic, thrombo-embolic and infectious diseases. Physiopathology is still unclear, but the association with inflammatory diseases evokes an immune pro-inflammatory pathway.
The prevalence of PHG has been estimated in two papers. In 1980 Ulbright reported 2 cases of PHG in a population of 86 patients with solitary necrotic granuloma of the lung 4 . In 2012
Peng reported 1 case of PHG in a population of 481 patients with diffuse parenchymal lung disease 5 .
Here we report 5 new cases of PHG and provide an exhaustive review of all cases reported in the literature, focusing on clinical presentation, diagnosis modalities, treatment response, long-term outcomes and associated-diseases.
PATIENTS AND METHODS
Patients' selection
After interrogation of French internal medicine physicians, chest physicians and pathologists, ten patients with PHG were identified. The diagnosis was confirmed by histology in all cases.
In 5 cases, medical data were insufficient. Data were extracted from medical records and demographic, clinical, biological and radiographic data were collected. Histology was reviewed when available by a pathologist with a strong experience in lung disease especially PHG (FC). Because PHG may be associated with mediastinal a retroperitoneal fibrosis and that one case was previously reported associated with hyperIgG4, the available cases (case 1 and case 2) were stained with an anti IgG4 antibody according to manufacturer instructions.
Literature review
We searched through the National Library of Medicine's MEDLINE database for relevant literature using the key words "hyalinizing granuloma". The demographic and clinical characteristics, diagnosis modalities, associated diseases and biological results were collected.
Follow-up and outcomes
The treatments were collected for all cases when available. The primary end-point was the radiological evolution of the nodule at last visit. For the literature cases, the radiological outcome (stable, improved or worsened) was noted from the papers.
Statistical analysis
The statistical analysis was performed with GraphPad V6.0 (San Diego, CA). The qualitative data were described with percentages. The quantitative data were reported with median or mean when appropriate and range. The outcomes for patients treated and not treated were compared with Fisher's exact test. All tests were bilateral and p-values < 0.05 were considered as statistically significant.
RESULTS
Reported cases
Clinical, biological and radiological findings of reported cases are presented in No more treatment was made, and follow up did not found evolution at 2 years for one patient. One patient present pulmonary embolism of the right proximal pulmonary artery and seven months later, a pneumothorax occurred; a corticosteroid treatment was introduced without improvement of lung nodule. Two patients were treated with corticosteroid and cyclophosphamide for associated mediastinal fibrosis with improvement of lung lesion but don't prevent death in one case after compression of cardiac cavity by fibrosis.
Literature review
We studied 135 patients from 80 articles between 1964 and 2015 in the English, French, Spanish, Italian, German, Turk, Polish, Chinese and Japanese literature.
Demographic and clinical characteristics
Demographic and clinical characteristics of all patients (our series and literature, n=135) are presented in Table 2 .
The mean age at PHG diagnosis was 44.6 years (range: 15-83 yrs). There was a male predominance (82 males/57 females); the sex was not reported in one observation. The ethnic group was known in 79 cases (56.4 %) of cases : european were predominant (n=32, 40.5 %), followed by african or afroamerican (n=19, 24%), asiatic (n=15, 29.1%), arabs or middle east people (n=11, 13.9%) and indian (n=2, 2.5%). Thirty-one patients were active smokers (31/52, 59.6%) with a 32.5 pack-year median consummation.
The working activity was reported in 22 cases (15.1 %) and an environmental exposition was found in 14/22 cases (63.6 %) (factory worker, maid, cement worker, chemistry industry, cotton industry, pet shop, old locomotive driver, mine worker). Asbestos exposure was reported in two of our patients.
The patients were asymptomatic in 38 observations (27.1 %). Respiratory symptoms were reported in 77 cases (55 %) with cough (n= 44, 31.4 %), chest pain/pleural effusion (n= 29, 20.7 %), dyspnea (n= 29, 20.7%) and hemoptysis (n= 11, 7.9%). General symptoms were also reported with fever (n= 15, 10.7), loss of weight (n= 13, 9.3%), asthenia (n= 9, 6.4%), night sweats (n= 5) and lymphadenopathy (n= 1).
Most of extra-respiratory symptoms were due to extra respiratory localizations of PHG and/or associated pathology (dysphagia, headache, diplopy, abdominal mass, cutaneous/mandibular localization, uveitis, etc…). Extra respiratory localizations of hyalinizing granuloma with histologic confirmation were (n = 19.13.6%): skin (n =4 ) 5, 48, 68, 71 , tonsillar or subglottic area (n =3 ) 2, 14, 35 , pleural localization (n= 1) 36 , optic nerve (n =1) 66 , pituitary gland (n =1) 66 , liver (n =1) case 1 , joints (n = 1) 35 , spleen (n =1) 23 , pericardium (n =1) 23 , and abdominal mass (n =1) 35 .
Pathological conditions associated with PHG
Pathological conditions associated with PHG are presented in Table 3 .
PHG was associated with an infection in 19 cases (14.1 %). Tuberculosis was the most common (n= 14) 2, 7, 9, 30, 36, 48, 50, 65, 69, 72, 73, 74 . One case of infection with the Human Immunodeficiency virus (HIV) was reported in association with PHG 65 .
PHG was associated with an auto-immune disease in 17 cases (12.1%): Grave's disease (n=2 including case 1) 43 , sarcoidosis (n=2 including case 4) 75 , cutaneous vasculitis (n=2) 2, 6 , antiphospholipid syndrome (n=1) 60 , idiopathic thrombocytopenic purpura (n=3) 78, 53, 79 , multiple sclerosis (n=1) 28 , rheumatoid arthritis (n=1) 10 , Riedel disease (n=1) 16 , Sjögren syndrome (n=1) 82 , auto-immune thyroïditis (n=3) 16 , IgA nephropathy (n=1) 70 , hyperIgG4 syndrome (n=1) 75 Castleman's disease (n=1) 27 .
PHG was associated with a solid tumor in 6 cases (4.4 %): breast Paget disease (n=1) 18 , lung adenocarcinoma (n=1) 2 , meningioma (n=1) 60 , anaplastic astrocytoma (n=1) 26 , thyroid carcinoma (n=1) 73 and basocellular carcinoma (n=1, case 4).
PHG was associated with thromboembolic disease in 8 cases: peripheral venous thrombosis (n=4) 25, 49, 60, 69 , ischemic cardiac disease (n=2) 32,34 pulmonary embolism (n=1) case 4 , stroke (n=1) 34 . Other pathologies were reported but with no evidence of relationship with PHG (spontaneous echymosis, nasal polyposis, alcohol behavior (including 1 with liver transplantation), gout, adenomyosis.
Radiological findings
The results of thoracic imaging with chest X ray or chest CT scan were reported in 138
cases. The most frequent finding was nodular lesions (n = 128, 92.7%) isolated (n = 37, In rare cases, a lung parenchymal infiltration or condensation was found, alone or in association with nodules.
The 18FDG-PET scan results were reported in 15 cases. Nine patients (60%) displayed hypermetabolism of the nodules, with standard uptake variation (SUV) ranging from 2.2 to 9.6.
Biological characteristics
The biological results were reported in 72 cases (49.6 % Histoplasme serology was always negative (n=4). When BAL was realized, microbiological tests were always negative excepted in 2 cases (histoplasma (n=1) 68 and aspergillus(n=1) 44 ).
In one case a typical histoplasomis granuloma was found 10 .
Respiratory function
The respiratory function was evaluated in 21 cases and was abnormal in 15. Moderate obstructive syndrome was found in 12 cases and restrictive syndrome in 3. In 5 cases, patients were treated with others therapies in addition to corticosteroids.
Diagnosis, treatment and outcomes
Corticosteroids were associated with cyclophosphamide in 2 patients for mediastinal fibrosis (leading to decrease of nodule size in these 2 cases), intravenous immunoglobulins, Due to the hypothesis of an infectious disease associated to PHG, antibiotics, antifungal therapy and antitubercular drugs were given in several observations, but they were never effective.
Among the 135 cases, 9 patients died during follow-up (7%). Two deaths 38, 67 were related to PHG. One of the patients died after 30 years of interstitial lung disease and PHG diagnosis was made after autopsy 38 . The second patient died after compression of the right cardiac cavity by a lung nodular lesion 67 . The other causes of deaths were infectious pneumonia (n =4) 26, 34, 52, 60 , acute hemolytic anemia (n=1) 10 refractory mediastinal fibrosis (n= 1, case 1)
and myeloma (n = 1) We identified 5 new patients with PHG and reviewed the 135 cases of the literature.
According to our results, PHG is a rare disease typically occurring in Caucasian middle age men, frequently active smoker. PHG may be asymptomatic (27.8%). In radiological explorations, nodules are isolated (28.9%) or multiple (71.1%) and are frequently in 18FDG
PET scan (60%). The diagnosis of PHG is always confirmed by histology. CT-guided percutaneous needle biopsy seems to be effective in nodular lung disease 5 but worst in PHG with diagnosis in 28.6% of the cases. When the diagnosis is not achieved, wedge resection leads to the diagnosis. When a wedge resection is not possible, lobectomy should be considered because of the risk of malignancy.
In the previously reported cases, PHG was often associated with mediastinal (13.6%) or retroperitoneal (8.6%) fibrosis, autoimmune (12.1%), infectious (13.6%) tumoral, haematological and thromboembolic diseases.
Due to the association with systemic fibrosis [83] and autoimmune disease, an immune abnormal reaction has been evoked to explain the PHG formation. Infectious trigger could alo be considered due to the association with some infectious diseases. This association between infection disease and autoimmune disease has been often suggested [84] . Despite the analysis of the literature, the physiopathology of PHG remains unclear and even if tuberculosis, auto-immune diseases and tumoral diseases seem to be frequently associated with PHG, they do not seem to be the cause of the disease. Due to association with systemic fibrosis, association with IgG4 syndrome was evoked and reports in one case, in our series no case of hyperIgG4 syndrome was found.
Histology is necessary for diagnosis. Currently there is no imaging or metabolic test which allows to differentiate PHG from others diagnosis, especially lung neoplasma. As reported by Peng 4 CT guided percutaneous needle biopsy should be efficient for lung disease diagnosis.
Our analysis of the literature confirmed the efficiency of CT guided needle biopsy to diagnose PHG.
When the diagnosis is confirmed, these associated pathologies have to be searched because they are important for outcome, prognosis and therapy.
Outcome is often good. Corticosteroids may improve the natural evolution of PHG, but rarely necessary. PHG does not frequently cause the death of patients. The low evolution of this pathology allows an active follow up and permits a reduction of corticosteroid impregnation.
Conclusion PHG is a rare disease with a good prognosis mimicking lung neoplasm. Diagnosis required invasive strategy for histology. This pathology usually does not need treatment but corticosteroids seem efficient when necessary. PHG is frequently associated with infectious, auto immune and neoplasm diseases which have to be search. These pathologies lead the prognosis and treatment is more associated to their presence than to respiratory symptoms of PHG. No treatment n=46
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